These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6178592)

  • 61. Inhibition of natural killer cell activity by serum from patients with systemic lupus erythematosus: roles of disease activity and serum interferon.
    Ytterberg SR; Schnitzer TJ
    Ann Rheum Dis; 1984 Jun; 43(3):457-61. PubMed ID: 6204601
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Immunomodulation of human leukocytes by staphylococcal enterotoxin A: augmentation of natural killer cells and induction of suppressor cells.
    Platsoucas CD; Oleszak EL; Good RA
    Cell Immunol; 1986 Feb; 97(2):371-85. PubMed ID: 2943428
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Enhancement of NK, but not K cell activity by different interferons.
    Rumpold H; Kraft D; Scheiner O; Meindl P; Bodo G
    Int Arch Allergy Appl Immunol; 1980; 62(2):152-61. PubMed ID: 6154652
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Treatment of patients with disseminated colorectal cancer with recombinant human alpha 2-interferon. Studies on the immune system.
    Einhorn S; Wasserman J; Lundell G; Blomgren H; Cedermark B; Jarstrand C; Petrini B; Strander H; Theve T; Ohman U
    Int J Cancer; 1984 Feb; 33(2):251-6. PubMed ID: 6229496
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Serum beta2-microglobulin and carcino-embryonic antigen in cancerous patients. A preliminary study of 258 cases (author's transl)].
    Pouillart P; Magdelenat H; Palangie T; Gongora R
    Pathol Biol (Paris); 1978 Sep; 26(6):363-5. PubMed ID: 83587
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effect of human fibroblast interferon on natural killer cell activity: stimulation in vitro and inhibition in vivo.
    Heidemann E; Reichmann U; Wilms K; Treuner J; Niethammer D
    Klin Wochenschr; 1982 Jun; 60(12):625-9. PubMed ID: 6180219
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Alpha interferon treatment in myasthenia gravis: effects on natural killer cell activity.
    Bolay H; Karabudak R; Aybay C; Candemir H; Varli K; Imir T; Kansu E
    J Neuroimmunol; 1998 Mar; 82(2):109-15. PubMed ID: 9585806
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Comparison of the biologic effects of two recombinant human interferons alpha (rA and rD) in humans.
    Hawkins MJ; Borden EC; Merritt JA; Edwards BS; Ball LA; Grossbard E; Simon KJ
    J Clin Oncol; 1984 Mar; 2(3):221-6. PubMed ID: 6321691
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Restoring Natural Killer Cell Cytotoxicity After Hyperthermia Alone or Combined with Radiotherapy.
    Hietanen T; Kapanen M; Kellokumpu-Lehtinen PL
    Anticancer Res; 2016 Feb; 36(2):555-63. PubMed ID: 26851009
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Natural killer cell activity in hepatocellular carcinoma. In vitro and in vivo responses to interferon.
    Dunk AA; Novick D; Thomas HC
    Scand J Gastroenterol; 1987 Dec; 22(10):1245-50. PubMed ID: 2448865
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The protective effect of interferon against natural killing activity is not mediated via the expression of class I MHC antigens.
    Reiter Z; Fischer DG; Rubinstein M
    Immunol Lett; 1988 Apr; 17(4):323-8. PubMed ID: 2453457
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Hcmv-miR-UL112 attenuates NK cell activity by inhibition type I interferon secretion.
    Huang Y; Chen D; He J; Cai J; Shen K; Liu X; Yang X; Xu L
    Immunol Lett; 2015 Feb; 163(2):151-6. PubMed ID: 25530545
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Differential action of six human interferons against two human carcinomas growing in nude mice.
    Balkwill FR; Goldstein L; Stebbing N
    Int J Cancer; 1985 May; 35(5):613-7. PubMed ID: 2581901
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Ganoderma tsugae mycelium enhances splenic natural killer cell activity and serum interferon production in mice.
    Won SJ; Lin MT; Wu WL
    Jpn J Pharmacol; 1992 Jun; 59(2):171-6. PubMed ID: 1279250
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Enhanced expression of melanoma-associated antigens and beta 2-microglobulin on cultured human melanoma cells by interferon.
    Liao SK; Kwong PC; Khosravi M; Dent PB
    J Natl Cancer Inst; 1982 Jan; 68(1):19-25. PubMed ID: 6172626
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Antibody to staphylococcal enterotoxin A-induced human immune interferon (IFN gamma).
    Langford MP; Weigent DA; Georgiades JA; Johnson HM; Stanton GJ
    J Immunol; 1981 Apr; 126(4):1620-3. PubMed ID: 6162895
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Pharmacokinetic study of partially pure gamma-interferon in cancer patients.
    Gutterman JU; Rosenblum MG; Rios A; Fritsche HA; Quesada JR
    Cancer Res; 1984 Sep; 44(9):4164-71. PubMed ID: 6430557
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Parameters of interferon action: II. Immunological effects of recombinant leukocyte interferon (IFN-alpha 2) in phase I-II trials.
    Ernstoff MS; Fusi S; Kirkwood JM
    J Biol Response Mod; 1983; 2(6):540-7. PubMed ID: 6607324
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Neutralizing antibodies against human leukocyte, lymphoblastoid and fibroblast interferons elicited by immunization with human leukocyte interferon.
    Pyhälä
    Acta Pathol Microbiol Scand C; 1978 Dec; 86C(6):291-8. PubMed ID: 726897
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Natural killer (NK) cell activity in mice with acute graft-versus-host reactions: characterization of a Thy-1+ NK-like cell with a broadened spectrum of lytic activity in the spleen and lymph nodes.
    MacDonald GC; Gartner JG
    Scand J Immunol; 1991 May; 33(5):553-65. PubMed ID: 1709518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.